Observational studyInvestigative ophthalmology & visual science2026
Outer Retinal Volume on Macular OCT Predicts Two-Year Diabetic Retinopathy Progression.
Observational study in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: To evaluate whether baseline retinal volume from macular optical coherence tomography (OCT) is associated with diabetic retinopathy (DR) progression over two years. Methods: In this longitudinal observational study, 190 eyes from 121 patients, across the DR severity spectrum without diabetic macular edema, completed two-year follow-up and were included in the analysis. Baseline 3 × 3-mm macular OCT scans, with manual correction of segmentation, were analyzed to derive inner and outer retinal volumes in the central subfield, 1-3 mm parafoveal area, and whole 3 × 3-mm scan. Disease progression was defined as having one or more of the following events: DR worsening on fluorescein angiography or vision loss ≥ 10 letters at the two-year timepoint, or development of vitreous hemorrhage or initiation of pan-retinal photocoagulation or anti-VEGF therapy at any point during follow-up. Generalized Estimating Equations were used for analysis. Results: Of the 190 eyes (121 patients), 48 eyes (25.3%; 39 patients) demonstrated progression. Higher outer retinal volume (parafoveal and whole) at baseline was significantly associated with disease progression (P < 0.001), whereas inner retinal volume showed no significant association. After adjusting for baseline DR severity, hypertension, age, lens and Bonferroni correction, outer retinal volume remained independently associated with higher odds of progression (P < 0.001). Conclusions: Increased outer retinal volume (parafoveal and entire 3 × 3-mm macular scan) predicts DR progression over two years. These findings highlight the prognostic value of OCT-derived outer retinal volume and support its potential role as a clinically accessible biomarker for identifying eyes at higher risk for DR complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.